Clarity Pharmaceuticals Ltd Stock
Stocks
CU6
AU0000165375
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
13:10:13 29/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1.670 AUD | +6.71% |
|
-6.18% | -50.59% |
| Market Cap | 623M 438M 393M 362M 328M 613M 41.76B 4.32B 1.72B 21.85B 1.65B 1.61B 69.21B | P/E 2027 * |
-5.27x | P/E 2028 * | -6.27x |
|---|---|---|---|---|---|
| Enterprise Value | 559M 393M 352M 325M 294M 550M 37.47B 3.88B 1.55B 19.61B 1.48B 1.45B 62.1B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 16.2x |
| Free-Float |
78.88% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| CU6 | Delayed | |
OTC Markets
| CLRPF | Delayed | |
|
Tradegate
| 1F4 | Real-time | |
|
Deutsche Boerse AG
| 1F4 | Delayed |
| 1 day | +6.71% | ||
| 1 week | -6.18% | ||
| Current month | -20.48% | ||
| 1 month | -17.73% | ||
| 3 months | -21.23% | ||
| 6 months | -43.39% | ||
| Current year | -50.59% |
| 1 week | 1.52 |  | 1.69 |
| 1 month | 1.52 | | 2.15 |
| Current year | 1.52 | | 4.26 |
| 1 year | 1.52 | | 5.14 |
| 3 years | 1 | | 8.98 |
| 5 years | 0.36 | | 8.98 |
| 10 years | 0.36 | | 8.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michelle Parker
CEO | Chief Executive Officer | - | 11/10/2024 |
Matthew Harris
CEO | Chief Executive Officer | - | 01/01/2010 |
David Green
DFI | Director of Finance/CFO | - | 04/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Taylor
CHM | Chairman | - | 01/11/2013 |
Rosanne Robinson
BRD | Director/Board Member | - | 01/10/2010 |
Chris Roberts
BRD | Director/Board Member | 72 | 29/03/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/4/26 | Sell | Chief Executive Officer | 360,896 | 0.0969% | ||
| 28/11/25 | Free | Chief Operating Officer | 199,909 | 0.0537% | ||
| 28/11/25 | Free | Chief Operating Officer | 287,530 | 0.0773% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.71% | -6.18% | -63.46% | +59.05% | 411M | |
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | |
| +0.98% | +2.68% | +12.25% | +83.90% | 55.53B | |
| +1.75% | +2.01% | +13.30% | +105.71% | 53.03B | |
| -1.43% | -1.17% | +26.27% | +55.26% | 45.99B | |
| -0.48% | -2.80% | +18.01% | +99.11% | 42.45B | |
| +0.82% | +1.37% | +227.94% | +936.89% | 40.45B | |
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | |
| -2.07% | +42.73% | +103.77% | +90.26% | 34.47B | |
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | |
| Average | +0.34% | +3.41% | +40.90% | +153.08% | 39.3B | |
| Weighted average by Cap. | -0.10% | +3.13% | +49.44% | +161.05% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 33.03M 23.25M 20.82M 19.21M 17.38M 32.51M 2.21B 229M 91.44M 1.16B 87.25M 85.39M 3.67B |
| Net income | -121M -84.95M -76.09M -70.19M -63.52M -119M -8.09B -837M -334M -4.23B -319M -312M -13.41B | -101M -71.13M -63.72M -58.78M -53.19M -99.47M -6.77B -701M -280M -3.55B -267M -261M -11.23B |
| Net Debt | -64M -45.04M -40.34M -37.22M -33.68M -62.98M -4.29B -444M -177M -2.24B -169M -165M -7.11B | -87M -61.23M -54.84M -50.6M -45.79M -85.62M -5.83B -604M -241M -3.05B -230M -225M -9.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | A$1.670 | +6.71% | 4,411,106 |
| 28/10/26 | A$1.565 | +0.97% | 4,140,307 |
| 27/10/26 | A$1.550 | -1.59% | 3,714,069 |
| 26/10/26 | A$1.575 | +0.32% | 3,615,863 |
| 23/10/26 | A$1.570 | -6.27% | 5,180,808 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CU6 Stock
Select your edition
All financial news and data tailored to specific country editions
